Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA Conference Paper uri icon

Overview

publication date

  • October 1, 1999

Research

keywords

  • Conference paper

Identity

Digital Object Identifier (DOI)

  • 10.1097/00000658-199910000-00002

PubMed ID

  • 10522716

Additional Document Info

start page

  • 466

end page

  • 472

volume

  • 230